Leap Therapeutics Inc (NASDAQ: LPTX) started the day on Wednesday, with a price increase of 10.19% at $2.92, before settling in for the price of $2.65 at the close. Taking a more long-term approach, LPTX posted a 52-week range of $1.68-$5.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -20.00%. Meanwhile, its Annual Earning per share during the time was 28.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 53.42%. This publicly-traded company’s shares outstanding now amounts to $38.32 million, simultaneously with a float of $28.55 million. The organization now has a market capitalization sitting at $111.89 million. At the time of writing, stock’s 50-day Moving Average stood at $2.91, while the 200-day Moving Average is $2.65.
Leap Therapeutics Inc (LPTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Leap Therapeutics Inc’s current insider ownership accounts for 25.48%, in contrast to 31.82% institutional ownership.
Leap Therapeutics Inc (LPTX) Earnings and Revenue Records
Leap Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 53.42% and is forecasted to reach -1.28 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -2.49% through the next 5 years, which can be compared against the 28.36% growth it accomplished over the previous five years trading on the market.
Leap Therapeutics Inc (NASDAQ: LPTX) Trading Performance Indicators
Let’s observe the current performance indicators for Leap Therapeutics Inc (LPTX). It’s Quick Ratio in the last reported quarter now stands at 3.97. The Stock has managed to achieve an average true range (ATR) of 0.30.
In the same vein, LPTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.93, a figure that is expected to reach -0.40 in the next quarter, and analysts are predicting that it will be -1.28 at the market close of one year from today.
Technical Analysis of Leap Therapeutics Inc (LPTX)
If we take a close look at the recent performances of Leap Therapeutics Inc (NASDAQ: LPTX), its last 5-days Average volume was 0.38 million that shows progress from its year to date volume of 0.24 million. During the previous 9 days, stock’s Stochastic %D was recorded 36.57% While, its Average True Range was 0.28.
Raw Stochastic average of Leap Therapeutics Inc (LPTX) in the period of the previous 100 days is set at 35.29%, which indicates a major fall in contrast to 39.48% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 71.03% that was lower than 83.61% volatility it exhibited in the past 100-days period.
